US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014
11/28/2014 | published by: GlobalData
... (RSV) Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. It includes an overview of the trial numbers and their recruitment status ...  |  read more...
USD 2,500
Lung Cancer Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to ...  |  read more...
USD 995
Pneumonia Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pneumonia Partnering 2009-2014 provides understanding and access to the pneumonia partnering deals and agreements entered into by the worlds ...  |  read more...
USD 695
Cystic Fibrosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Pulmonary Hypertension Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Pulmonary Hypertension in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Cystic Fibrosis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals Top cystic fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Cystic Fibrosis Partnering 2009-2014 provides understanding and access to the cystic fibrosis partnering deals and agreements ...  |  read more...
USD 695
Respiratory Disorders Pipeline Highlights Database – 2015
11/5/2014 | published by: Fore Pharma
... Respiratory Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and Chronic). The ...  |  read more...
USD 2,800
Bronchitis-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Lower Respiratory Tract Infections-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Respiratory Tract Infections-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Obstructive Pulmonary Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Global Pulmonary Drug Delivery Systems Market 2015-2019
11/19/2014 | published by: TechNavio - Infiniti Research Ltd.
... route of administration for the non-invasive delivery of drugs is mostly preferred because of the large surface area for absorption, high blood circulation, and high permeability rate. Pulmonary drug delivery offers various advantages over peroral ...  |  read more...
USD 3,000
Upper Respiratory Tract Infections -API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Bronchitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Chronic Bronchitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Lower Respiratory Tract Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Pulmonary Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Pulmonary Embolism Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Idiopathic Pulmonary Fibrosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Respiratory Distress Syndrome Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Upper Respiratory Tract Disorders Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Bacterial Pneumonia-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Bacterial Pneumonia. This report provides information on the therapeutic development based on the Bacterial Pneumonia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Bronchiolitis-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Bronchiolitis. This report provides information on the therapeutic development based on the Bronchiolitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Bronchitis-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Bronchitis. This report provides information on the therapeutic development based on the Bronchitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
1    3    5  6  7  8  9  10